Home NDC 0409-2267-20 Labetalol Hydrochloride
Product NDC 0409-2267
Requested package NDC 0409-2267-20
11-digit product format 004092267
Labeler code 0409
Product ID 0409-2267_61e69fb9-661f-4fc2-bf5d-e722dfa6b434
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Labetalol Hydrochloride
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Hospira, Inc.
Application ANDA075240
Marketing category ANDA
Marketing start 2005-12-30
Marketing end 0000-00-00
Substance LABETALOL HYDROCHLORIDE
Active strength 5 mg/mL
Pharmacologic classes Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0409-2267 0409-2267-20 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0409-2267 0409-2267-20 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075240-001 LABETALOL HYDROCHLORIDE LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A075240-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A075240-001 LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE / INJECTION AP RS 1999-11-29 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0409-2267-20 Labetalol Hydrochloride 20 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 20 28 0409-2267-20 Labetalol Hydrochloride 1 in 1 CARTON INJECTION, SOLUTION 1 28 0409-2267-54 Labetalol Hydrochloride 40 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 40 28 0409-2267-54 Labetalol Hydrochloride 1 in 1 CARTON INJECTION, SOLUTION 1 28
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT 1GEV3BAW9J LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 LABETALOL ACTIVE MOIETY R5H8897N95 LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 ANHYDROUS DEXTROSE INACTIVE INGREDIENT 5SL0G7R0OK LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 13 LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT 1GEV3BAW9J LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 LABETALOL ACTIVE MOIETY R5H8897N95 LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 ANHYDROUS DEXTROSE INACTIVE INGREDIENT 5SL0G7R0OK LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0409-2267 LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] 25 Legacy NDC, 4 package rows 20241210_abfc6b75-1ed5-41f1-0484-4597488237bc.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0409-2267-20 00409226720 1 VIAL, MULTI-DOSE in 1 CARTON (0409-2267-20) > 20 mL in 1 VIAL, MULTI-DOSE 2006-02-01 0000-00-00 No No Current